Debt-to-equity of 10x Genomics, Inc. from 30 Jun 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
10x Genomics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2020 to 30 Sep 2025.
  • 10x Genomics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 29%, a 1.7% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

10x Genomics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 29% -1% -1.7% 30 Sep 2025
Q2 2025 28% 0% -0.7% 30 Jun 2025
Q1 2025 29% +1% +4.4% 31 Mar 2025
Q4 2024 29% +2% +6.9% 31 Dec 2024
Q3 2024 29% +3% +10% 30 Sep 2024
Q2 2024 29% +2% +6.6% 30 Jun 2024
Q1 2024 28% 0% +0.14% 31 Mar 2024
Q4 2023 27% 0% +0.18% 31 Dec 2023
Q3 2023 27% 0% +0.95% 30 Sep 2023
Q2 2023 27% +2% +6.6% 30 Jun 2023
Q1 2023 28% +3% +13% 31 Mar 2023
Q4 2022 27% +2% +8.6% 31 Dec 2022
Q3 2022 26% +1% +4.2% 30 Sep 2022
Q2 2022 25% -1% -2.9% 30 Jun 2022
Q1 2022 24% -5% -18% 31 Mar 2022
Q4 2021 25% -9% -26% 31 Dec 2021
Q3 2021 25% -14% -35% 30 Sep 2021
Q2 2021 26% -19% -42% 30 Jun 2021
Q1 2021 30% 31 Mar 2021
Q4 2020 34% 31 Dec 2020
Q3 2020 39% 30 Sep 2020
Q2 2020 44% 30 Jun 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.